These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34788337)

  • 1. ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection.
    Mielke D; Bandawe G; Zheng J; Jones J; Abrahams MR; Bekker V; Ochsenbauer C; Garrett N; Abdool Karim S; Moore PL; Morris L; Montefiori D; Anthony C; Ferrari G; Williamson C
    PLoS Pathog; 2021 Nov; 17(11):e1010046. PubMed ID: 34788337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway.
    Mielke D; Bandawe G; Pollara J; Abrahams MR; Nyanhete T; Moore PL; Thebus R; Yates NL; Kappes JC; Ochsenbauer C; Garrett N; Abdool Karim S; Tomaras GD; Montefiori D; Morris L; Ferrari G; Williamson C
    Front Immunol; 2019; 10():2875. PubMed ID: 31921139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.
    Dupuy FP; Kant S; Barbé A; Routy JP; Bruneau J; Lebouché B; Tremblay C; Pazgier M; Finzi A; Bernard NF
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
    Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
    EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-specific antibodies capable of ADCC are common in breastmilk and are associated with reduced risk of transmission in women with high viral loads.
    Mabuka J; Nduati R; Odem-Davis K; Peterson D; Overbaugh J
    PLoS Pathog; 2012; 8(6):e1002739. PubMed ID: 22719248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early low-titer neutralizing antibodies impede HIV-1 replication and select for virus escape.
    Bar KJ; Tsao CY; Iyer SS; Decker JM; Yang Y; Bonsignori M; Chen X; Hwang KK; Montefiori DC; Liao HX; Hraber P; Fischer W; Li H; Wang S; Sterrett S; Keele BF; Ganusov VV; Perelson AS; Korber BT; Georgiev I; McLellan JS; Pavlicek JW; Gao F; Haynes BF; Hahn BH; Kwong PD; Shaw GM
    PLoS Pathog; 2012; 8(5):e1002721. PubMed ID: 22693447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited neutralizing antibody specificities drive neutralization escape in early HIV-1 subtype C infection.
    Moore PL; Ranchobe N; Lambson BE; Gray ES; Cave E; Abrahams MR; Bandawe G; Mlisana K; Abdool Karim SS; Williamson C; Morris L; ;
    PLoS Pathog; 2009 Sep; 5(9):e1000598. PubMed ID: 19763271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies.
    Bruel T; Guivel-Benhassine F; Lorin V; Lortat-Jacob H; Baleux F; Bourdic K; Noël N; Lambotte O; Mouquet H; Schwartz O
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancing Virion Tethering by BST2 Sensitizes Productively and Latently HIV-infected T cells to ADCC Mediated by Broadly Neutralizing Antibodies.
    Pham TN; Lukhele S; Dallaire F; Perron G; Cohen ÉA
    Sci Rep; 2016 Nov; 6():37225. PubMed ID: 27853288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-HIV-1 antibody-dependent cellular cytotoxicity: is there more to antibodies than neutralization?
    Lee WS; Kent SJ
    Curr Opin HIV AIDS; 2018 Mar; 13(2):160-166. PubMed ID: 29194123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combination antiretroviral therapy on human immunodeficiency virus 1 specific antibody responses in subtype-C infected children.
    Kumar S; Batra H; Singh S; Chawla H; Singh R; Katpara S; Hussain AW; Das BK; Lodha R; Kabra SK; Luthra K
    J Gen Virol; 2020 Dec; 101(12):1289-1299. PubMed ID: 32915123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Envelope Glycoproteins Proteolytic Cleavage Protects Infected Cells from ADCC Mediated by Plasma from Infected Individuals.
    Prévost J; Medjahed H; Vézina D; Chen HC; Hahn BH; Smith AB; Finzi A
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies.
    Lynch RM; Wong P; Tran L; O'Dell S; Nason MC; Li Y; Wu X; Mascola JR
    J Virol; 2015 Apr; 89(8):4201-13. PubMed ID: 25631091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of a monoclonal antibody reactive against the C1C2 of Env obtained from a patient infected with HIV-1 CRF02_AG.
    Md Zahid H; Kuwata T; Takahama S; Kaku Y; Biswas S; Matsumoto K; Tamamura H; Matsushita S
    Retrovirology; 2021 Aug; 18(1):23. PubMed ID: 34419098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope.
    Anthony C; York T; Bekker V; Matten D; Selhorst P; Ferreria RC; Garrett NJ; Karim SSA; Morris L; Wood NT; Moore PL; Williamson C
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28679760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete Downregulation of CD4 Expression Affects HIV-1 Env Conformation and Antibody-Dependent Cellular Cytotoxicity Responses.
    Prévost J; Richard J; Medjahed H; Alexander A; Jones J; Kappes JC; Ochsenbauer C; Finzi A
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved killing of HIV-infected cells using three neutralizing and non-neutralizing antibodies.
    Tuyishime M; Garrido C; Jha S; Moeser M; Mielke D; LaBranche C; Montefiori D; Haynes BF; Joseph S; Margolis DM; Ferrari G
    J Clin Invest; 2020 Oct; 130(10):5157-5170. PubMed ID: 32584790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies.
    von Bredow B; Arias JF; Heyer LN; Moldt B; Le K; Robinson JE; Zolla-Pazner S; Burton DR; Evans DT
    J Virol; 2016 Jul; 90(13):6127-6139. PubMed ID: 27122574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible beneficial effects of neutralizing antibodies and antibody-dependent, cell-mediated cytotoxicity in human immunodeficiency virus infection.
    Sawyer LA; Katzenstein DA; Hendry RM; Boone EJ; Vujcic LK; Williams CC; Zeger SL; Saah AJ; Rinaldo CR; Phair JP
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):341-56. PubMed ID: 1971182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond Viral Neutralization.
    Lewis GK; Pazgier M; Evans DT; Ferrari G; Bournazos S; Parsons MS; Bernard NF; Finzi A
    AIDS Res Hum Retroviruses; 2017 Aug; 33(8):760-764. PubMed ID: 28084796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.